Table 2.
Patient demographics—controlled studies (treated patients)
| Demographics | Fentanyl ITS | Morphine IV PCA | Placebo | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| <65 years (N = 1264) | 65–74 years (N = 325) | 75–84 years (N = 158) | >85 years (N = 16) | <65 years (N = 931) | 65–74 years (N = 234) | 75–84 years (N = 135) | >85 years (N = 13) | <65 years (N = 250) | 65–74 years (N = 44) | 75–84 years (N = 20) | >85 years (N = 2) | |
| Age [mean (SEM)] | 46.9 (0.29) | 69.4 (0.17) | 78.2 (0.20) | 86.8 (0.43) | 47.4 (0.34) | 69.3 (0.19) | 78.1 (0.22) | 87.3 (0.54) | 46.8 (0.69) | 68.5 (0.45) | 79.1 (0.60) | 88.5 (1.50) |
| Sex | ||||||||||||
| Female [n (%)] | 890 (70.4) | 177 (54.5) | 95 (60.1) | 12 (75.0) | 621 (66.7) | 135 (57.7) | 90 (66.7) | 4 (30.8) | 181 (72.4) | 30 (68.2) | 14 (70.0) | 2 (100) |
| Male [n (%)] | 374 (29.6) | 142 (45.5) | 63 (39.9) | 4 (25.0) | 310 (33.3) | 99 (42.3) | 45 (33.3) | 9 (69.2) | 69 (27.6) | 14 (31.8) | 6 (30.0) | 0 |
| Race/ethnicity | ||||||||||||
| Caucasian [n (%)] | 1027 (81.3) | 291 (89.5) | 148 (93.7) | 16 (100) | 758 (81.4) | 219 (93.6) | 126 (93.3) | 13 (100) | 208 (83.2) | 42 (95.5) | 19 (95.0) | 2 (100) |
| Black [n (%)] | 149 (11.8) | 17 (5.2) | 5 (3.2) | 0 | 123 (13.2) | 10 (4.3) | 5 (3.7) | 0 | 20 (8.0) | 2 (4.5) | 0 | 0 |
| Asian [n (%)] | 13 (1.0) | 3 (0.9) | 0 | 0 | 7 (0.8) | 0 | 0 | 0 | 2 (0.8) | 0 | 0 | 0 |
| Hispanic [n (%)] | 46 (3.6) | 10 (3.1) | 4 (2.5) | 0 | 32 (3.4) | 3 (1.3) | 3 (2.2) | 0 | 13 (5.2) | 0 | 1 (5.0) | 0 |
| Polynesian [n (%)] | 13 (1.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 (2.4) | 0 | 0 | 0 |
| Other [n (%)] | 16 (1.3) | 4 (1.2) | 1 (0.6) | 0 | 11 (1.2) | 2 (0.9) | 1 (0.7) | 0 | 1 (0.4) | 0 | 0 | 0 |
| BMI (kg/m2) [mean (SEM)] | 29.4 (0.21) | 28.7 (0.35) | 27.5 (0.40) | 25.4 (1.22) | 29.8 (0.26) | 29.2 (0.42) | 27.1 (0.41) | 25. 7 (1.18) | 28.8 (0.40) | 28.6 (0.88) | 26.9 (1.29) | 22.2 (1.32) |
| Surgery type [n (%)] | ||||||||||||
| Orthopedic bone | 466 (36.9) | 191 (58.8) | 108 (68.4) | 9 (56.3) | 360 (38.7) | 154 (65.8) | 103 (76.3) | 9 (69.2) | 96 (38.4) | 25 (56.8) | 13 (65.0) | 0 |
| Upper abdominal | 76 (6.0) | 12 (3.7) | 9 (5.7) | 0 | 48 (5.2) | 12 (5.1) | 6 (4.4) | 0 | 7 (2.8) | 4 (9.1) | 0 | 2 (100) |
| Thoracic/chest | 9 (0.7) | 5 (1.5) | 0 | 0 | 3 (0.3) | 1 (0.4) | 0 | 0 | 4 (1.6) | 1 (2.3) | 2 (10.0) | 0 |
| Lower abdominal | 665 (52.6) | 101 (31.1) | 38 (24.1) | 6 (37.5) | 462 (49.6) | 63 (26.9) | 23 (17.0) | 2 (15.4) | 142 (56.8) | 12 (27.3) | 4 (20.0) | 0 |
| Other | 48 (3.8) | 16 (4.9) | 3 (1.9) | 1 (6.3) | 58 (6.2) | 4 (1.7) | 3 (2.2) | 2 (15.4) | 1 (0.4) | 2 (4.5) | 1 (5.0) | 0 |
BMI body mass index, ITS iontophoretic transdermal system, IV PCA intravenous patient-controlled analgesia, SEM standard error of measure